About this trial
The first aim of the observational study is the translation, cross-cultural adaptation and validation of functional and behavioral scales used in the diagnosis of neurodegenerative diseases, for which a formal version in Italian is not available at present. In particular, the study includes the following functional and behavioral scales: the Katz's index (Basic Activities of Daily Living, BADL), the Lawton and Brody's scale (Instrumental Activities of Daily Living, IADL), the Everyday Cognition questionnaire (E-Cog), the Neuropsychiatric Inventory Questionnaire (NPI-Q) for assessing the Behavioral and Psychological Symptoms of Dementia. Furthermore, a modified Italian version of the Functional Activities Questionnaire (FAQ), which integrates and updates the content of the original items (e.g., addressing the use of technologies, M-FAQ) will be used in the validation study.
The second aim is to evaluate the psychometric properties of the M-FAQ, the ECog, and the NPI-Q in terms of reliability and validity.
The third aim is to apply a Receiver Operating Characteristic (ROC) curve analysis to identify cut-offs of IADL, M-FAQ and ECOG to discriminate between different clinical groups (i.e., neurologically unimpaired elderly; Subjective Cognitive Decline, SCD; Mild Cognitive Impairment, MCI; mild Alzheimer's Disease, AD).
Neurologically unimpaired elderly participants (over 60 years old) and participants with SCD, MCI, mild AD, and their caregivers/informants will undergo: i) administration of the translated versions of the scales; ii) administration of a Cognitive Reserve questionnaire. For SCD, MCI and AD participants, data from the clinical neuropsychological evaluation will also be collected, while paper-and-pencil psychometric tests to assess global cognitive functioning (Mini Mental State Examination) and logical-abstract reasoning (Raven's Colored Matrices) will be administered to the neurologically unimpaired participants.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age ≥ 60 years;
Availability of an informant/caregiver, able to judge their functional abilities.
Subjective Cognitive Decline (Jessen et al., 2014)
Mild Cognitive Impairment (Winblad et al., 2004)
Disqualifiers
Refusal or inability to sign informed consent;
For the clinical groups: other neurological or psychiatric conditions that may explain the presence of cognitive difficulties.
Trial population
The study will enroll neurologically unimpaired participants and participants with SCD, MCI, and mild dementia referred to the Center for Cognitive Disorders and Dementia.
Trial design
Other
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Everyday Cognition questionnaire score
The tool assesses functional changes in specific cognitive domains (memory, language, visuospatial skills, and executive functions).
Secondary outcomes
Basic Activities of Daily Living (BADL) score
The tool assesses functional autonomy in simple everyday activities.
Instrumental Activities of Daily Living (IADL) score
The tool assesses functional autonomy in instrumental everyday activities.
Functional Activities Questionnaire (FAQ) score
The tool assesses functional autonomy in complex everyday activities
Neuropsychiatric Inventory Questionnaire (NPI-Q) score
The tool assesses Behavioral and Psychological Symptoms of Dementia (BPSD) , covering a wide range of neuropsychiatric symptoms.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.